Emulsion Polymer Market Will Be $56.86 Million By 2024: Grand View Research, Inc.

The global Emulsion Polymer Market is expected to reach USD 56.86 million by 2024, according to a new report by Grand View Research, Inc. Acrylic use for superabsorbent polymers and personal care products is increasing on account of their quick drying ability and water resistance characteristics. Such favorable characteristics are anticipated to augment overall industry demand. 

Increasing construction spending, particularly in Asia Pacific and the Middle East, has prompted the demand for paints & coatings in the recent past. The growth of paints & coatings industry has had a direct impact on emulsion polymer demand. Stringent environmental regulations to control noxious chemical emissions coupled with increasing preference for greener products are expected to limit synthetic based demand and augment bio-based and water based product demand. Volatile prices of key raw materials are expected to remain a key challenge for market participants over the forecast period. 

Acrylics was the leading product segment and accounted for 39.3% of total market volume in 2015. High demand for diapers & training pants and personal care particularly in the emerging markets of Asia Pacific is expected to drive this segment over the forecast period. It is also expected to witness the highest growth of 6.0% from 2016 to 2024.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/emulsion-polymer-market

Further key findings from the report suggest:

• The global emulsion polymer market demand was 13.36 million tons in 2015 and is expected to reach 21.88 million tons by 2024, growing at a CAGR of 5.7% from 2016 to 2024
• Paints& coatings emerged as the leading application segment with demand share exceeding 35% in 2015. Increasing construction activities in China, India, South Korea and the Middle East coupled with a positive outlook on the global automotive industry is expected to drive this segment over the forecast period.
• Asia Pacific was the leading regional market with demand share estimated 40% in 2015. Rapid urban construction has increased the paint consumption which in turn is expected to fuel the global market. Asia Pacific is also expected to witness the fastest growth of 7.2% from 2016 to 2024.
• Key players operating in the global emulsion polymer market include Nuplex industry, Synthomer, STI polymer, Wacker Chemie AG, BASF, Omnova Solutions, Styron, Clariant International Limited, and DIC Corporation. Product innovation coupled with expansion strategies are expected to be adopted by the mid-sized manufacturers to increase their global presence.

Grand View Research has segmented the emulsion polymer market on the basis of product, application and region:

Global Emulsion Polymer Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

• Acrylics
• Styrene-Butadiene Latex
• Vinyl Acetate Polymers
• Others

Global Emulsion Polymer Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

• Paints and Coating
• Paper and Paperboard coating
• Adhesives
• Others

Global Emulsion Polymer Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

• North America
  • US
  • Mexico
• Europe
  • European Union (EU)
  • Russia
  • Turkey
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East and Africa

Access Full Press Release Of This Report: www.grandviewresearch.com/press-release/emulsion-polymer-market-report

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Animal Health Market Size Would Be Around $64.6 Billion By 2025 | CAGR: 5.5%: Grand View Research, Inc.

The global animal health market size is expected to reach USD 64.6 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 5.5% during the forecast period. Rapid technological advancements in veterinary care are likely to provide an upthrust to the market. For instance, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, emergence of veterinary health information systems, specifically in developed economies, is poised to help the market gain significant momentum over the coming years.

With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. Incorporation of this technology will facilitate real-time analysis of fluctuations in disease prevalence. As a consequence of aforementioned factors, it is projected that there will be remarkable improvement in the overall penetration rate of animal health products, which is also anticipated to spur the growth of the market.

To request a sample copy or view summary of this report, click the link below: 

www.grandviewresearch.com/industry-analysis/animal-health-market

Further key findings from the report suggest:

• Vaccines are expected to exhibit a noteworthy CAGR during the forecast period due to significant increase in adoption of companion animals that demand long-term health check-ups
• The companion animal segment is estimated to expand at a higher CAGR during the same period owing to associated health benefits for humans such as lower blood pressure, greater psychological stability, and reduced anxiety attacks
• Veterinary hospitals and clinics accounted for a substantial share in 2017, owing to increasing number of hospital pharmacies coupled with high procedural volume as a consequence of frequent readmission of pets for treatment
• Retail channels and E-commerce platform commanded a sizeable cumulative share owing to factors such as high convenience associated with online pharmacies and increasing number of retail pharmacies
• Point-of-care testing is the fastest growing end-use segment due to surging demand for highly productive animals and growing investments in R&D activities for novel animal products
• In 2017, North America represented the largest share in the global animal health market owing to local presence of established pharmaceutical companies, consistently striving for extensive commercialization of their products
• Asia Pacific is expected to progress at a phenomenal CAGR due to dire clinical urgency to curb high incidence of zoonotic diseases and growing focus on management of disease outbreaks such as swine influenza and Ebola
• The key participants employ sustainability strategies, such as expanding product portfolio to gain competitive advantage. For instance, In March 2016, Merial entered into distribution agreement with Zoetis, Inc. to expand dairy product portfolio in India

Grand View Research has segmented the global animal health market on the basis of animal type, product, distribution channel, end use, and region:

Animal Health Animal Type Outlook (Revenue, USD Million, 2014 - 2025)

• Production Animal
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
• Companion Animal
  • Dogs
  • Cats
  • Horses
  • Others

Animal Health Product Outlook (Revenue, USD Million, 2014 - 2025)

• Vaccines
  • Live Attenuated Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Feed Additives
  • Nutritional
  • Medicinal
• Diagnostics
  • Instruments
  • Consumables

Animal Health Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Retail
• E-commerce
• Veterinary Hospitals & Clinics

Animal Health End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

Animal Health Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
  • Spain
  • Netherlands
  • Switzerland
  • Sweden
  • Ireland
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Israel

Browse Press release of this Report: www.grandviewresearch.com/press-release/global-animal-health-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Facial Injectables Market Size Would Be Around $17.2 Billion By 2025: Grand View Research, Inc.

The global Facial Injectables Market is expected to reach USD 17.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to exhibit lucrative growth during the forecast period, owing to advancements in facial rejuvenation procedures and increasing importance of medical aesthetics across the globe.

Development in products & procedures, as well as change in patient demographics is helping dermatologists and physicians treat multiple facial areas. These advancements help dermatologists or physicians develop customized treatment for patients and facilitate use of combination products to obtain better outcomes. All these factors are expected to assist in the market growth over the forecast period. Augmented products such as Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) fillers are used in combination to improve outcomes, especially in the lower face procedures. HA fillers are mostly preferred by physicians due to their better acceptance (few instances of hypersensitivity reactions), biodegradable nature, & high viscosity as well as for the longevity they provide to the restored volume.

Minimally invasive surgery, an advanced medical technology, is used for facial rejuvenation, endoscopy, laparoscopy, arthroscopy and other procedures. This procedure is gaining popularity over time owing to faster recovery, low instances of postsurgery infections, lower pain, reduced scarring, and high accuracy & maximum benefits. For instance, as per International Society of Aesthetic Plastic Surgery (ISAPS), more than 20.0 million surgical and nonsurgical cosmetic procedures were performed worldwide in 2014.The number of HA-based surgeries performed in 2014 was 2,690,633, which increased to 2,865,086 in 2015, which is thereby expected to contribute to the growth of this space over the forecast period.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/facial-injectables-industry

Further key findings from the study suggest:

• The hyaluronic acid segment held a lucrative share in 2016 and is expected to grow at a significant rate over the forecast period owing to increasing preference for combination treatments such as hyaluronic acid with BoNTA.
• The BoNTA segment is anticipated to witness the fastest growth over the forecast period due to increasing application in aesthetics and therapeutics
• The aesthetics segment is expected to dominate the market during the forecast period owing to increasing expenditure on aesthetic procedures coupled with rising beauty consciousness among consumers
• North America is expected to dominate the facial injectables market over the forecast period due to growing geriatric population base, increasing consumer disposable income, and surge in number of facial procedures in the region
• Some of the key players in facial injectables market are ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma S.A.

Grand View Research has segmented the global facial injectables market on the basis of product, application, and region:

Facial Injectables Product Outlook (Revenue, USD Million, 2014 - 2025)

• Collagen
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Polymer Fillers
  • Polymethylmethacrylate Beads (PMMA Microspheres)
  • Poly-L-lactic acid (PLLA)

Facial Injectables Application Outlook (Revenue, USD Million, 2014 - 2025)

• Aesthetics
• Therapeutics

Facial Injectables Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-kaolin-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bathroom and Toilet Assist Devices Market Is Poised To Reach $6.0 Billion By 2025: Grand View Research, Inc.

The global bathroom and toilet assist devices market size is expected to reach USD 6.0 billion by 2025 at a 6.2% CAGR, according to a new report by Grand View Research, Inc. Growth in prevalence of chronic diseases, coupled with aging population, has resulted in a rise in individuals with various disabilities. This has significantly driven the global market.

Aging demographics has created a demand for old-age homes and long-term care centers, both of which drive demand for bathroom and toilet assist devices. In addition, rising disposable income and government support toward home healthcare is supporting market growth.

On the other hand, longer product life cycle is primarily challenging the growth of the market. In addition, reusability of these devices is restraining revenue generation. However, growth in demand for these devices is predicted to lower the effect of the above-mentioned factors.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/bathroom-toilet-assist-devices-market

Further key findings from the report suggest:

• Commodes emerged as the largest product segment as a result of the many benefits offered such as improved adjustability, enhanced ease, and flap on seats
• Bath lifts and aids form the fastest growing segment owing to increase in number of patients with spinal injuries, which has spurred demand for various forms of mobility assist devices
• North America dominated the market in terms of revenue in 2016. Improved awareness regarding commercially available assist devices and increasing disposable income are propelling revenue generation in the region
• Europe is projected to witness swift growth during the forecast period owing to speedy adoption of advanced bathroom and toilet assist devices for patients with disabilities, to facilitate and reduce mobility issues
• Key players include ArjoHuntleigh; Medical Device Depot; Carex Health Brands; Juvo Solutions; Bischoff & Bischoff GmbH; Invacare Corporation; Prism Medical; Sunrise Medical LLC; and GF Health Products, Inc.

Grand View Research has segmented the global bathroom and toilet assist devices market on the basis of product and region:

Bathroom and Toilet Assist Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Shower Chairs and Stools
  • Shower Chairs
  • Shower Stools
  • Others
• Bath Lifts
  • Fixed Bath Lifts
  • Reclining Bath Lifts
  • Lying Bath Lifts
  • Others
• Toilet Seat Raisers
• Commodes
  • Shower and Toilet Commodes
  • Toilet Commodes
• Handgrips and Grab Bars
• Bath Aids

Bathroom and Toilet Assist Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Browse Press Release of this Report:  www.grandviewresearch.com/press-release/global-bathroom-toilet-assist-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Drug Discovery Outsourcing Market Is Posied To Reach $4.4 Billion By 2025: Grand View Research, Inc.

The global Drug Discovery Outsourcing Market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by Grand View Research, Inc. Urging need to identify potential drug candidates for various chronic diseases is anticipated to fuel growth.

Technological advances in in silico drug designing and accelerating integration of Artificial Intelligence (AI) in drug discovery are driving industry progress. Multiple applications of AI algorithms in drug design and discovery provide opportunities for players to offer specialized drug discovery services. It is useful for processes such as target and compound selection, predictive analytics, screening, and drug repurposing.

Projected rise in adoption of outsourcing over the forecast period is expected to boost market revenue generation. Half of the drug discovery processes are anticipated to be outsourced, thereby creating massive opportunities for CROs, CMOs, and CDMOs to expand their market presence.

Number of collaborations among these organizations, key pharmaceutical players, and several universities has increased over the past few years. This rise in alliance further supports the projected increase in growth potential.

High cost and high risk of drug failure are major challenges faced in drug discovery. However, advances in technology that increase efficiency of drug discovery, coupled with increased adoption of highly advanced technology to provide specialized services, allow outsourcing companies to overcome these challenges.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/drug-discovery-outsourcing-market

Further key findings from the report suggest:

• Escalating incidence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is projected to indirectly propel market growth. Advancements in technologies, such as emergence of Artificial Intelligence (AI) in the pharmaceutical industry, is also anticipated to accelerate industry progress
• Moreover, increasing incidences of antibiotic resistance as well as drug resistance have improved focus on discovery of novel compounds to treat conditions such as Multidrug-Resistant TB (MDR-TB)
• Based on workflow, lead identification and candidate optimization is slated for impressive growth owing to high bottlenecks in this workflow segment
• By therapeutic area, oncology drug discovery outsourcing is fueled by increasing demand for oncology solutions, coupled with expanding government support in cancer research
• North America dominates the global market owing to high focus on R&D in identification of novel drug candidates, along with presence of key players
• Asia Pacific is projected to witness the fastest growth over the forecast period as a result of increasing number of CRO, CMOs, and CDMOs in emerging countries. Rising trend of outsourcing manufacturing and R&D activities to countries such as China and India will aid growth in the region
• Some of the major players are Charles River; EVOTEC, Laboratory Corporation of America Holdings; GenScript, Merck & Co., Inc.; Jubilant Biosys; Thermo Fisher Scientific, Inc.; Oncodesign; Albany Molecular Research, Inc.; WuXi AppTec; Dalton Pharma Services; Pharmaceutical Product Development, LLC; DiscoverX Corporation; and QIAGEN
• Collaboration of players with key pharmaceutical companies and academics and research centers is observed to increase in recent years.

Grand View Research has segmented the global drug discovery outsourcing market on the basis of workflow, therapeutic area, drug type, and region:

Drug Discovery Outsourcing Workflow Outlook (Revenue, USD Million, 2013 - 2025)

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development
• Other Associated Workflow

Drug Discovery Outsourcing Therapeutic Area Outlook (Revenue, USD Million, 2013 - 2025)

• Respiratory System
• Pain and Anesthesia
• Oncology
• Ophthalmology
• Hematology
• Cardiovascular
• Endocrine
• Gastrointestinal
• Immunomodulation
• Anti-Infective
• Central Nervous System
• Dermatology
• Genitourinary System

Drug Discovery Outsourcing Drug Type Outlook (Revenue, USD Million, 2013 - 2025)

• Small Molecules
• Large Molecules (Biopharmaceuticals)

Drug Discovery Outsourcing Regional Outlook (Revenue, USD Million, 2013 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

Browse Press release of this Report: www.grandviewresearch.com/press-release/global-drug-discovery-outsourcing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Elemental Analysis Market Is Estimated To Generate Revenue Around $2.02 Billion By 2025: Grand View Research, Inc.

The global elemental analysis market is expected to reach USD 2.02 billion by 2025, growing at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. The market is primarily driven by amendments in the ICH (International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) regulations that mandate use of elemental analysis for finished medical products, including pharmaceuticals.

Many manufacturers of elemental analyzers invest in R&D of new and technologically advanced products. In addition to their expenses for R&D, many key players launched new products in the market in the past 3 years. For instance, in May 2016, Agilent Technologies launched Agilent 5110 ICP-OES, which was designed to enable scientists perform fast and precise elemental analysis of pharmaceuticals and food products along with mining, industrial, and environmental analysis.

In addition, in many countries, the limit of heavy metals/trace elements is regulated by their respective pharmacopeias. For instance, United States, Japanese, and European pharmacopeias limit the amount of trace elements in finished pharmaceutical products. Furthermore, elemental analysis is a crucial step before commercial launch of a medical product in the market.

North America held the largest market share in 2016. Local presence of large number of manufacturers, regulation of limits of trace elements/heavy metals by United States Pharmacopeia (USP), and ongoing research for development of new products are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. Rise in interest of market players to expand their business in Asia Pacific, growing awareness on safety of pharmaceuticals, and increase in expenditure by local pharmaceutical companies on elemental analyzers are factors that can be attributed for the highest growth rate of Asia Pacific region during the forecast period.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/elemental-analysis-market

Further Key Findings From the Report Suggest:

• The inorganic elements segment held the largest revenue share in 2016 due upcoming mandates for elemental analysis in medical products
• Nondestructive technologies held the largest revenue share of the market, by technology, in 2016. Retention of sample after analysis and high precision rate can be the key factors for largest share of this segment
• North America dominated the global market due to presence of USP regulations that limit the amount of heavy metals/trace elements
• Some of the key players arePerkinElmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and Analytik Jena AG; among others

Grand View Research, Inc. has segmented the elemental analysis market on the basis of type of elements analyzed, technologies used, and region:

Elemental Analysis Type of Elements Outlook (Revenue, USD Million, 2014 - 2025)

• Organic Elements
• Inorganic Elements

Elemental Analysis Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Destructive Technologies
  • ICP-MS
  • ICP-OES
  • Combustion Analysis
  • Other destructive technologies
• Nondestructive Technologies
  • XRF
  • FTIR
  • Other nondestructive technologies

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Access Full Press Release Of This Report: www.grandviewresearch.com/press-release/global-elemental-analysis-market

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Glass Additives Market Size Would Be $1.56 Billion By 2025 | CAGR: 3.6%: Grand View Research, Inc.

The global glass additives market is expected to reach USD 1.56 billion by 2025, according to a new report by Grand View Research, Inc. Increasing consumption of colored and specialty glass in the packaging industry has been a major factor driving the glass additives market growth.

Rising demand from food & beverage industry in addition to the growing popularity for customized glass wares across industries such as pharmaceuticals, cosmetics, etc. are expected to contribute to the demand for glass packaging.  High demand for glass packaging will, in turn, is projected to spur the glass additives industry.

Demand for durable glass with enhanced properties such as water repellent, UV protection, anti-glare, etc. from automotive, electronics and construction industries has triggered the usage of metal oxides and nanoparticles during glass production. Utilization of additives in the glass helps in accelerating the manufacturing process thereby reducing the overall energy consumption. It also contributes in bringing down the total manufacturing costs.

The glass industry is slowly reviving from the recent downturn. The industry witnessed the closure of many production units around the world during past decade. Most of the glass manufacturers are focusing on product differentiation and cost advantage. Use of additives helps these manufacturers for long-term existence.

The additives industry is oligopolistic in nature with top few players holding a greater chunk of the market share. Some of the major players in the glass additives market include DuPont, Gillinder Glass, SCHOTT, Torrecid Group, and Nanobase.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/glass-additives-market

 
Further key findings from the report suggest:

• The global glass additives demand reached to 35,428.4 tons in 2016 and is expected to grow at a CAGR of 3.3% from 2017 to 2025
• Europe emerged as the largest consumer in 2016 and is estimated to generate revenue over USD 533.8 million by 2025
• Metal oxide demand as glass additives was valued at USD 403.1 million in 2016 and is projected to witness a growth of 3.6% over the forecast period
• Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of key developing economies such as China, which is the largest producers of rare earth elements. The regional demand is expected to grow at a CAGR of 3.7% from 2016 to 2025
• Key players including Torrecid Group, Gillinder Glass, DuPont, Ferro Corporation, SCHOTT dominated the glass additives market and accounted for over 50% of the total volume in 2015

Grand View Research has segmented the global glass additives market on the basis of product, end-use, and region:

Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Metal Oxide
• Nanoparticles
• Rare Earth Metals
• Others

End-use Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Packaging
• Building & Construction
• Electronics & Appliances
• Others

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
• Middle East & Africa 

Access Full Press Release Of This Report: www.grandviewresearch.com/press-release/global-glass-additives-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com